​

Funding Round

Series B - ChromaCode

Series B - ChromaCode

Investment Firm

Overview

ChromaCode is a molecular diagnostics company focusing on bioinformatics.

Announced Date

Apr 27, 2017

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

New Enterprise Associates

New Enterprise Associates

New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

3

Investor Name
Participant InvestorDomain Associates
Participant InvestorNew Enterprise Associates
Participant InvestorOkapi Venture Capital

Round Details and Background

ChromaCode raised $12000000 on 2017-04-27 in Series B

ChromaCode is a molecular diagnostics company focusing on bioinformatics.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 16, 2021
Grant - ChromaCode
1-6.0M
Mar 03, 2022
Venture Round - ChromaCode
-38.0M
Jun 07, 2023
Series D - ChromaCode
1-undefined
Apr 27, 2017
Series B - ChromaCode
3-12.0M

Recent Activity

There is no recent news or activity for this profile.